pulmonía

Last changed on 06 August 2020 - 14:28

New studies and clinical reports confirm that MLS® Laser Therapy is useful for contributing to the treatment of patients with COVID-19 pneumonia.

Used as a complementary treatment to standard drug therapy, MLS® alleviates acute inflammatory events caused by an excessive production of pro-inflammatory cytokines and favours pulmonary functional recovery.